Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li C Cheung

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
The Journal of Infectious Diseases|January 20, 2026
Risk-based prophylactic HPV vaccination of heterosexual US men aged 27 to 45 years for prevention of oropharyngeal cancerAnil K Chaturvedi, Gregory Haber, Barry I Graubard, et al.
Annals of Internal Medicine|June 4, 2019
Contemporary Implications of U.S. Preventive Services Task Force and Risk-Based Guidelines for Lung Cancer Screening Eligibility in the United StatesRebecca Landy, Li C Cheung, Christine D Berg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2021
Management of Lung Cancer Screening Results Based on Individual Prediction of Current and Future Lung Cancer RisksHilary A Robbins, Li C Cheung, Anil K Chaturvedi, et al.
Preventive Medicine|July 10, 2022
A comparison of high-grade cervical abnormality risks in women living with and without human immunodeficiency virus undergoing routine cervical-cancer screeningPhilip E Castle, Brian Befano, Mark Schiffman, et al.
Journal of the National Cancer Institute|June 3, 2024
Primary human papillomavirus testing vs cotesting: clinical outcomes in populations with different disease prevalenceShrutikona Das, Nicolas Wentzensen, George F Sawaya, et al.
Annals of Internal Medicine|June 22, 2026
Benefits and Harms of Immediate Versus Delayed Treatment of Cervical Intraepithelial Neoplasia Grade 2 : A Target Trial EmulationLi C Cheung, Fangya Mao, Greg Rydzak, et al.
BMJ (Clinical Research Ed.)|November 29, 2023
Untreated cervical intraepithelial neoplasia grade 2 and subsequent risk of cervical cancer: population based cohort studyKathrine Dyhr Lycke, Johnny Kahlert, Lone Kjeld Petersen, et al.
Statistics in Medicine|June 30, 2017
Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health recordsLi C Cheung, Qing Pan, Noorie Hyun, et al.
Journal of the National Cancer Institute|June 27, 2024
The risk and benefit profiles of US-eligible lung cancer screening attendees vs nonattendeesElizabeth Y Zhang, Li C Cheung, Hormuzd A Katki, et al.
Preventive Medicine|December 31, 2017
Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotestingKatharine A Rendle, Mark Schiffman, Li C Cheung, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|January 20, 2026
Risk-based prophylactic HPV vaccination of heterosexual US men aged 27 to 45 years for prevention of oropharyngeal cancerAnil K Chaturvedi, Gregory Haber, Barry I Graubard, et al.
Annals of Internal Medicine|June 4, 2019
Contemporary Implications of U.S. Preventive Services Task Force and Risk-Based Guidelines for Lung Cancer Screening Eligibility in the United StatesRebecca Landy, Li C Cheung, Christine D Berg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2021
Management of Lung Cancer Screening Results Based on Individual Prediction of Current and Future Lung Cancer RisksHilary A Robbins, Li C Cheung, Anil K Chaturvedi, et al.
Preventive Medicine|July 10, 2022
A comparison of high-grade cervical abnormality risks in women living with and without human immunodeficiency virus undergoing routine cervical-cancer screeningPhilip E Castle, Brian Befano, Mark Schiffman, et al.
Journal of the National Cancer Institute|June 3, 2024
Primary human papillomavirus testing vs cotesting: clinical outcomes in populations with different disease prevalenceShrutikona Das, Nicolas Wentzensen, George F Sawaya, et al.
Annals of Internal Medicine|June 22, 2026
Benefits and Harms of Immediate Versus Delayed Treatment of Cervical Intraepithelial Neoplasia Grade 2 : A Target Trial EmulationLi C Cheung, Fangya Mao, Greg Rydzak, et al.
BMJ (Clinical Research Ed.)|November 29, 2023
Untreated cervical intraepithelial neoplasia grade 2 and subsequent risk of cervical cancer: population based cohort studyKathrine Dyhr Lycke, Johnny Kahlert, Lone Kjeld Petersen, et al.
Statistics in Medicine|June 30, 2017
Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health recordsLi C Cheung, Qing Pan, Noorie Hyun, et al.
Journal of the National Cancer Institute|June 27, 2024
The risk and benefit profiles of US-eligible lung cancer screening attendees vs nonattendeesElizabeth Y Zhang, Li C Cheung, Hormuzd A Katki, et al.
Preventive Medicine|December 31, 2017
Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotestingKatharine A Rendle, Mark Schiffman, Li C Cheung, et al.
Pageof 10